LGT Fund Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
1,900
-1,600
-46% -$738K 0.04% 197
2026
Q1
$1.68M Sell
3,500
-6,800
-66% -$3.48M 0.07% 173
2025
Q4
$5.86M Buy
10,300
+7,100
+222% +$4.03M 0.46% 48
2025
Q3
$1.74M Sell
3,200
-440
-12% -$192K 0.14% 143
2025
Q2
$1.14M Buy
3,640
+2,060
+130% +$618K 0.1% 151
2025
Q1
$481K Hold
1,580
0.04% 187
2024
Q4
$525K Hold
1,580
0.05% 188
2024
Q3
$532K Buy
1,580
+280
+22% +$106K 0.06% 154
2024
Q2
$535K Buy
+1,300
New +$515K 0.07% 144

Other funds holding MEDP

LGT Fund Management's MEDP Position: Q2 2026 in Review

LGT Fund Management reduced its Medpace (MEDP) stake by 46% in Q2 2026, selling an estimated $738K and leaving 1,900 shares worth $1.01M. The position accounts for 0.04% of the portfolio, ranked #197.

LGT Fund Management first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.86M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • LGT Fund Management held 1,900 shares of Medpace worth $1.01M as of Q2 2026.
  • LGT Fund Management sold 1,600 Medpace shares in Q2 2026, an estimated $738K.
  • Medpace made up 0.04% of LGT Fund Management's portfolio in Q2 2026, its #197 holding.
  • LGT Fund Management first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • LGT Fund Management's Medpace position peaked at $5.86M in Q4 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on LGT Fund Management's 13F filing for Q2 2026, filed 10 Aug 2026.